Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
		
    IgG1 Fc N-glycan galactosylation as a biomarker for immune activation.
        
        Sci. Rep. 6:28207 (2016)
    
    
    
	    Immunoglobulin G (IgG) Fc N-glycosylation affects antibody-mediated effector functions and varies with inflammation rooted in both communicable and non-communicable diseases. Worldwide, communicable and non-communicable diseases tend to segregate geographically. Therefore, we studied whether IgG Fc N-glycosylation varies in populations with different environmental exposures in different parts of the world. IgG Fc N-glycosylation was analysed in serum/plasma of 700 school-age children from different communities of Gabon, Ghana, Ecuador, the Netherlands and Germany. IgG1 galactosylation levels were generally higher in more affluent countries and in more urban communities. High IgG1 galactosylation levels correlated with low total IgE levels, low C-reactive protein levels and low prevalence of parasitic infections. Linear mixed modelling showed that only positivity for parasitic infections was a significant predictor of reduced IgG1 galactosylation levels. That IgG1 galactosylation is a predictor of immune activation is supported by the observation that asthmatic children seemed to have reduced IgG1 galactosylation levels as well. This indicates that IgG1 galactosylation levels could be used as a biomarker for immune activation of populations, providing a valuable tool for studies examining the epidemiological transition from communicable to non-communicable diseases.
	
	
      Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Times Cited
Scopus
Cited By
		Cited By
Altmetric
		
	    5.288
		1.589
		42
		46
		
	    Annotations
	    
		
		     
		    
		
	    
	
		
	
	    Special Publikation
	    
		
		     
		
	    
	
	
	
	    Hide on homepage
	    
		
		     
		
	    
	
	
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
     
    
    
        Keywords
        Rheumatoid-arthritis; Antiinflammatory Activity; Humoral Responses; Gabonese Children; Serum Igg; Glycosylation; Association; Sialylation; Prevalence; Antibodies
    
 
     
    
    
        Language
        english
    
 
    
        Publication Year
        2016
    
 
     
    
        HGF-reported in Year
        0
    
 
    
    
        ISSN (print) / ISBN
        2045-2322
    
 
    
        e-ISSN
        2045-2322
    
 
    
     
     
	     
	 
	 
    
        Journal
        Scientific Reports
    
 
	
    
        Quellenangaben
        
	    Volume: 6,  
	    
	    
	    Article Number: 28207 
	    
	
    
 
    
         
        
            Publisher
            Nature Publishing Group
        
 
        
            Publishing Place
            London
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Reviewing status
        Peer reviewed
    
 
    
        Institute(s)
        Institute of Lung Health and Immunity (LHI)
    
 
    
        POF-Topic(s)
        30202 - Environmental Health
    
 
    
        Research field(s)
        Lung Research
    
 
    
        PSP Element(s)
        G-501600-001
    
 
     
     	
    
    
        WOS ID
        WOS:000378107700001
    
    
        Erfassungsdatum
        2016-07-15